olmesartan has been researched along with Masked Hypertension in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kario, K; Kushiro, T; Mori, Y; Okuda, Y; Saito, I; Shimada, K; Teramukai, S | 1 |
Kario, K; Kushiro, T; Okuda, Y; Saito, I; Sato, Y; Shimada, K; Teramukai, S | 1 |
2 other study(ies) available for olmesartan and Masked Hypertension
Article | Year |
---|---|
Effectiveness of olmesartan-based treatment on home and clinic blood pressure in elderly patients with masked and white coat hypertension.
Topics: Age Factors; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Diastole; Female; Follow-Up Studies; Humans; Imidazoles; Male; Masked Hypertension; Middle Aged; Office Visits; Prospective Studies; Systole; Tetrazoles; Treatment Outcome; White Coat Hypertension | 2015 |
Increased cardiovascular risk of treated white coat and masked hypertension in patients with diabetes and chronic kidney disease: the HONEST Study.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cardiovascular Diseases; Cardiovascular System; Diabetes Mellitus, Type 2; Female; Humans; Imidazoles; Male; Masked Hypertension; Middle Aged; Prospective Studies; Renal Insufficiency, Chronic; Risk Factors; Tetrazoles; White Coat Hypertension | 2017 |